Christian Angermayer

In 2000, Christian co-founded Ribopharma (original patents for RNAi technology) which merged with the stock market listed US SPAC Alnylam in 2003 and has a $13bn market cap today. Since then, Christian has created, co-founded, and invested in numerous successful companies, has raised over $2bn for his portfolio companies and has been involved in more than 50 successful IPO- and M&A transactions either as an entrepreneur, investor, or banker/advisor.

Christian Angermayer
Atai Life Sciences | Teambild
Atai Life Sciences
The Healing Company
The Healing Company
The New Meat Company AG | Vegan
The New Meat Company AG